Non-alcoholic fatty liver disease, obesity and other illnesses

Clinical and Investigative Medicine

Volumn 31, Issue 5, 2008, Pages

  Tarantino, Giovanni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; BARIATRIC SURGERY; CHOLELITHIASIS; CHRONIC KIDNEY DISEASE; CUSHING SYNDROME; MALNUTRITION; MENTAL STRESS; NONALCOHOLIC FATTY LIVER; NOTE; OBESITY; PERIODONTAL DISEASE; PRIORITY JOURNAL; THROMBOCYTOPENIA; VITAMIN D DEFICIENCY;

COMORBIDITY; DEVELOPED COUNTRIES; FATTY LIVER; HUMANS; OBESITY;

EID: 52949092280     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (27)

1. Hashimoto T, Fujita T, Usuda N, et al. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype. J Biol Chem 1999;274:19-36.
2. Day CP, James O. Steatohepatitis: a tale of two "hits"?, Gastroenterology 1998;114:842-5
3. Tarantino G, Marra M, Contaldo F, Pasanisi F. Basal metabolic rate in morbidly obese patients with non-alcoholic fatty liver disease. Clin Invest Med. 2008;31:24-9.
4. Adibi P, Sadeghi M, Mahsa M, Rozati G, Mohseni M. Prediction of coronary atherosclerotic disease with liver transaminase level. Liver Int. 2007;27:895-900.
5. Mustapha IZ, Debrey S, Oladubu M, Ugarte R. Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J Periodontol. 2007;78:2289-302.
6. Saito T, Shimazaki Y, Koga T, Tsuzuki M, Ohshima A. Relationship between periodontitis and hepatic condition in Japanese women. J Int Acad Periodontol 2006;8:89-95.
7. Holtmann M, Kopf D, Mayer M, Bechtinger E, Schmidt MH. Risperidone-associated steatohepatitis and excessive weight-gain. Pharmacopsychiatry 2003;36:206-7.
8. Chang Y, Ryu S, Sung E, Woo HY, Oh E, Cha K, Jung E, Kim WS. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism 2008;57:569-76.
9. Yener S, Akarsu M, Demir T, et al. Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis. J Endocrinol Invest 2007;30:810-9.
10. Simpson AJ, Booth NA, Moore NR, Lewis SJ, Gray RS. Circulating tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in proliferative diabetic retinopathy: a pilot study. Acta Diabetol 1999;36:155-8.
11. Lonardo A, Lombardini S, Scaglioni F, et al. Fatty liver, carotid disease and gallstones: a study of age-related associations. World J Gastroenterol 2006;12:5826-33.
12. Rodríguez-Hernández H, Gonzalez JL, Rodríguez- Morán M, Guerrero-Romero F. Hypomagnesemia, insulin resistance, and non-alcoholic steatohepatitis in obese subjects. Arch Med Res 2005;36:362-6.
13. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Long-term effect of magnesium consumption on the risk of symptomatic gallstone disease among men. Am J Gastroenterol 2008;103:375-82.
14. Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson JP, Besser GM, Grossman AB, Reznek RH. Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. Eur J Endocrinol 2003;149:543-8.
15. De Lusong MA, Labio E, Daez L, Gloria V. Non-alcoholic fatty liver disease in the Philippines: Comparable with other nations? World J Gastroenterol 2008;14:913-7.
16. Narita K, Murata T, Hamada T, et al. Associations between trait anxiety, insulin resistance, and atherosclerosis in the elderly: A pilot cross-sectional study. Psychoneuroendocrinology 2008;33:305-12.
17. Kudielka BM, Buske-Kirschbaum A, Hellhammer DH, Kirschbaum C. HPA axis responses to laboratory psychosocial stress in healthy elderly adults, younger adults, and children: impact of age and gender. Psychoneuroendocrinology 2004;29:83-98.
18. Charlton M, Angulo P, Chalasani N, et al. Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology 2008;47:484-92.
19. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Intern J Clin Pract 2003;57:258-61.
20. Veldman C, Cantorna M, DeLuca H. Expression of 1, 25 dihydroxyvitamin D3 receptor in the immune system. Arch Biochem Biophys 2000;374:334-8.
21. McCarty MF. Secondary hyperparathyroidism promotes the acute phase response - a rationale for supplemental vitamin D in prevention of vascular events in the elderly. Med Hypotheses 2005;64:1022-6
22. Johannessen A, Naman E, Ngowi BJ, et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis 2008;8:52.
23. Crum-Cianflone NF. Nonalcoholic fatty liver disease: an increasingly common cause of liver disease among HIV-infected persons? AIDS Read 2007;17:513-8.
24. Tarantino G, Conca P, Basile V, et al. Prospective study of acute drug-induced liver injury in patients suffering from non-alcoho lic fatty liver disease. Hepatol Res 2007;37:410-5.
25. Gómez V, Riall TS, Gómez GA. Outcomes in bariatric surgery in the older patient population in Texas. J Surg Res 2008;147:270-5.
26. Nomura R, Ishizaki Y, Suzuki K, Kawasaki S. Development of hepatic steatosis after pancreatoduodenectomy. AJR Am J Roentgenol 2007;189:1484-8.
27. Maple JT, Pearson RK, Murray JA, Kelly DG, Lara LF, Fan AC. Silent celiac disease activated by pancreaticoduodenectomy. Dig Dis Sci 2007;52:2140-4.